DUNCAN BARBARA GAYLE received a stock award from HALOZYME THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/29/2024ACC: 0001415889-24-011681
Director
Since Feb 2023
+15.30K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
15.30K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6.50K
Price / share
—
Trade value
—
% of position
70.3%
4/25/2024
9.25K→15.75K
Total
Net shares
+6.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/25/2024 | A · Award | +6.50K | — | — | 70.3% | 9.25K | 15.75K |
| Total | +6.50K | $0.00 | ||||||
Derivative Transactions1
Option to Purchase Common Stock
Direct
Converts to
Common Stock
8.80K shares
Shares
+8.80K
Strike price
38.46
Held after
8.80K
Exercisable
—
4/25/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock Direct | Common Stock8.80K shares | 4/25/2024 | A · Award | +8.80K | 38.46 | — | 8.80K |